🇺🇸 FDA
Pipeline program

SCB01A

SCB01A-22

Phase 2 small_molecule terminated

Quick answer

SCB01A for Head and Neck Neoplasms is a Phase 2 program (small_molecule) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Biotech Pharmaceutical Co.,
Indication
Head and Neck Neoplasms
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials